Hui Zhang, M.D., Ph.D., a St. Baldrick’s International Scholar, is the first researcher in mainland China to receive funding from St. Baldrick’s. See all the 2014 Summer Grants.
Dr. Zhang is a St. Baldrick’s International Scholar working to improve survival of children with ALL in China.
But in China, the most populous country in the world, that’s not the case.
In fact, not even 10 years ago, less than 10% of kids with ALL in China had access to protocol-based chemotherapy — treatment guided by years of research into understanding which drugs work better for which patient populations.
Thanks to a national health insurance scheme established in China in 2010, over 70% of newly diagnosed kids with ALL now have access to these treatments, but the cure rate for kids with ALL is still much lower in China than in the U.S. or other developed countries.
With over 10,000 kids in China diagnosed with ALL each year — more than three times the number of kids diagnosed in the U.S. — the need for more effective treatments is dire. And with more kids being treated than ever before, scientists in China have a unique opportunity to perform childhood cancer research on a large population — the key to improving overall survival for kids with ALL in China.
As a St. Baldrick’s International Scholar, Dr. Zhang will train for two to three years at St. Jude Children’s Research Hospital in Memphis, Tennessee, and then return to his home country to establish the first-ever network of pediatric ALL researchers in China.
While kids in China will clearly benefit from Dr. Zhang’s research, his work will contribute to scientists’ overall understanding of ALL — and that will help kids everywhere.
Dr. Zhang explains the impact of his International Scholar Grant:
You make children’s cancer research happen. Donate and see the impact your gift will make.
Read more about childhood cancer research on the St. Baldrick’s blog:
- International Scholars Grants Broaden the Borders of Childhood Cancer Research
- Thank You for Funding Childhood Cancer Research
- Research Funded by St. Baldrick’s Leads to Early Detection of Infant’s Rare Childhood Cancer
- Curing Childhood Cancer in the 21st Century: It’s Time for a Kid-centric Approach